CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 37 filers reported holding CERULEAN PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $31,000 | -31.1% | 44,255 | +3.5% | 0.00% | – |
| Q3 2016 | $45,000 | -50.5% | 42,773 | -0.1% | 0.00% | – |
| Q2 2016 | $91,000 | -22.9% | 42,830 | -1.9% | 0.00% | – |
| Q1 2016 | $118,000 | -10.6% | 43,643 | -7.5% | 0.00% | – |
| Q4 2015 | $132,000 | -21.0% | 47,201 | +3.5% | 0.00% | – |
| Q3 2015 | $167,000 | -1.2% | 45,605 | +24.5% | 0.00% | – |
| Q2 2015 | $169,000 | – | 36,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $20,448,000 | 16.18% |
| Polaris Venture Management Co IV LLC | 1,437,441 | $8,941,000 | 7.04% |
| Cormorant Asset Management, LP | 450,000 | $2,799,000 | 0.43% |
| Rock Springs Capital Management LP | 550,000 | $3,421,000 | 0.40% |
| Deer VII & Co. Ltd. | 166,675 | $1,037,000 | 0.31% |
| WALL STREET ASSOCIATES | 475,000 | $2,954,000 | 0.28% |
| Northeast Financial Consultants Inc | 20,000 | $124,000 | 0.06% |
| PRINCIPAL FINANCIAL GROUP INC | 295,200 | $1,836,000 | 0.00% |
| FMR LLC | 2,431,400 | $15,123,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 25,014 | $155,000 | 0.00% |